PRME
PRME
US74168J1016
Prime Medicine, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 4.632.000 2.983.000
55.3%
Cost of Revenue -- --
--
Gross Profit -- --
--
212.982.000 205.450.000
3.7%
Operating Income -208.350.000 -202.467.000
2.9%
Pretax Income -201.142.000 -195.882.000
2.7%
Net Income Common Stockholders -201.142.000 -195.882.000
2.7%
-- --
--
-- --
--
ende